BCM
TIL icon

Boxer Capital Management’s Instil Bio TIL Stock Holding History

Boxer Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60,700
Closed -$1.08M – 49
2025
Q3 		$1.08M Sell
60,700
-10,000
-14% -$254K 0.35% 31
2025
Q2 		$1.47M Sell
70,700
-9,425
-12% -$197K 0.74% 16
2025
Q1 		$1.39M Sell
80,125
-275,375
-77% -$5.71M 0.42% 24
2024
Q4 		$6.79M Buy
+355,500
New +$10.8M 0.58% 37

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boxer Capital Management's TIL Position: Q4 2025 in Review

Boxer Capital Management sold out of Instil Bio (TIL) in Q4 2025, closing a stake of 60,700 shares — an estimated $1.08M sold.

Boxer Capital Management first reported a position in TIL in Q4 2024 and held it in 4 quarters. The position peaked at $6.79M in Q4 2024. 29 funds tracked by Wall St. Rank hold TIL as of Q4 2025.

  • Boxer Capital Management reported no remaining Instil Bio position as of Q4 2025 after selling out during the quarter.
  • Boxer Capital Management sold 60,700 Instil Bio shares in Q4 2025, an estimated $1.08M.
  • Boxer Capital Management first reported a position in Instil Bio in Q4 2024 and held it in 4 quarters.
  • Boxer Capital Management's Instil Bio position peaked at $6.79M in Q4 2024.
  • 29 funds tracked by Wall St. Rank held Instil Bio as of Q4 2025.

Based on Boxer Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.